Dual‐Activatable Nano‐Immunomodulator for NIR‐II Fluorescence Imaging‐Guided Precision Cancer Photodynamic Immunotherapy
Advanced Science · 2024-12 · 11 (45)
DOI: 10.1002/advs.202409833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.10.2024. Verfasst von Shanchao Diao und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommu…. Hauptthemen laut MEDLINE: Photochemotherapy, Immunotherapy, Photosensitizing Agents, Optical Imaging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Research startup fund of NJUPT.
Abstract (Originalsprache)
Photodynamic immunotherapy which combines photodynamic therapy with immunotherapy has become an important and effective method for the treatment of cancer. However, most cancer photodynamic immunotherapeutic systems are not able to achieve precise release of immunomodulators, resulting in systemic side effects and poor patient outcomes. Herein, a dual‐activatable nano‐immunomodulator (DIR NP), which both its photodynamic effect and agonist release can be activated under specific stimuli, is reported for precision cancer photodynamic immunotherapy. The DIR NP is self‐assembled from an R848‐conjugated amphiphilic polymer (mPEG‐TK‐R848) and a hydrophobic oxidized bovine serum albumin (BSA‐SOH)‐conjugatable photosensitizer (DIR). DIR NPs may generate a small amount of 1 O 2 under 808 nm laser irradiation, leading to the cleavage of thioketal (TK) moiety and release of R848 and DIR. The released DIR may conjugate with tumor‐overexpressed BSA‐SOH, improving its photodynamic efficiency and NIR‐II fluorescence signal. Such photodynamic efficiency improvement may further enhance the release of cargoes upon irradiation. The activated photodynamic effect induces immunogenic cell death (ICD) to release immune factors and R848 can enhance the maturation of dendritic cells for inhibiting the growth of both primary and distant tumors and eliminating lung metastasis. Therefore, this study provides a dual‐activatable intelligent nano‐immunomodulator for precise regulation of tumor photodynamic immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing, 210023, China.
- The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
- Clinical Cancer Institute of Nanjing University, Nanjing, 210008, China.
ORCID-Profile: Chen Xie
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Research startup fund of NJUPT
- State Key Laboratory of Organic Electronics and Information Displays
- Nanjing University of Posts and Telecommunications
Zitieren
APA
Diao, S., Zhang, Z., Zhao, S., Li, Q., Zhang, X., Yang, X., Xu, Z., Liu, M., Zhou, W., Li, R., Xie, C., & Fan, Q. (2024). Dual‐Activatable Nano‐Immunomodulator for NIR‐II Fluorescence Imaging‐Guided Precision Cancer Photodynamic Immunotherapy. Advanced Science, 11(45). https://doi.org/10.1002/advs.202409833
Vancouver
Diao S, Zhang Z, Zhao S, Li Q, Zhang X, Yang X, et al. Dual‐Activatable Nano‐Immunomodulator for NIR‐II Fluorescence Imaging‐Guided Precision Cancer Photodynamic Immunotherapy. Advanced Science. 2024;11(45). doi:10.1002/advs.202409833
BibTeX
@article{Diao2024,
author = {Diao, Shanchao and Zhang, Zhifan and Zhao, Sijun and Li, Qiang and Zhang, Xiaolong and Yang, Xiangqi and Xu, Zhiwei and Liu, Mingming and Zhou, Wen and Li, Rutian and Xie, Chen and Fan, Quli},
title = {Dual‐Activatable Nano‐Immunomodulator for NIR‐II Fluorescence Imaging‐Guided Precision Cancer Photodynamic Immunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {45},
doi = {10.1002/advs.202409833}
}
EUVIMED